ADCYAP1 and Alzheimer disease: A promising non-invasive and easy route is intranasal application, by which PACAP reaches the brain fast and effectively in rodents, exerting neuroprotective effects in mouse models of AD (Rat et al., 2011; Nonaka et al., 2012) and HD (Cabezas-Llobet et al., 2018).